ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter

Japan to use data from outside clinical trials in drug approvals

Bid to speed up review process aimed at getting new medicines to market faster

Japan's health ministry will offer pharmaceutical companies more ways to show that their drugs are effective.

TOKYO -- Japan's health ministry will issue new guidelines next fiscal year aimed at helping new drugs get to market faster, by allowing pharmaceutical companies to use data from outside of clinical trials.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more